Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
amgen
drugs
new york
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alder biopharmaceutical
allergan
american academy of neurology
anylam pharmaceuticals
atogepant
biohaven
biotech
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cardiomyopathy
cholesterol
data
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
What
drug
year
3
×
big
fda
medicines
aces
ago
akcea
alnylam
amyloidosis
announced
approval
approved
arguments
attr
available
battle
ceo
cholesterol
class
commercialized
companies
competitors
debilitating
decades
disease
drugs
flexible
genetic
inclisiran
key
lowering
make
meant
medco
medicine
meeting
migraine
nasdaq
neuro
Language
unset
Current search:
year
×
" national top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments